Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06548594 · ClinicalTrials.gov registry record · NA
Out of State - tAN hEDS
A NA study of Hypermobile EDS (hEDS), sponsored by Medical University of South Carolina.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06548594 is a NA study of Hypermobile EDS (hEDS) that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06548594, a NA study of Hypermobile EDS (hEDS), is active but no longer recruiting, sponsored by Medical University of South Carolina.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypermobile EDS and hypermobile spectrum disorder (collectively referred to as hEDS) are estimated to affect 1 in 500 individuals worldwide. hEDS patients have limited treatment options for their numerous symptoms that impact the quality of life. This clinical trial tests a new ear stimulation method in hEDS patients to determine if it may improve quality of life.
Conditions Studied
Interventions
- DEVICE Transcutaneous Auricular Neurostimulation
Study Locations (1)
South Carolina
- Medical University of South Carolina Institute of Psychiatry - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06548594
The ClinicalTrials.gov registry entry for NCT06548594 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypermobile EDS (hEDS) appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Auricular Neurostimulation is the first listed.
NCT06548594 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06548594 about?
NCT06548594 is a clinical study titled "Out of State - tAN hEDS". Hypermobile EDS and hypermobile spectrum disorder (collectively referred to as hEDS) are estimated to affect 1 in 500 individuals worldwide. hEDS patients have limited treatment options for their numerous symptoms that impact the quality of life. This clinical trial tests a new ear stimulation metho...
What is the current status of trial NCT06548594?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-11-27. Estimated completion is 2026-04-01.
What conditions does trial NCT06548594 study?
This clinical trial studies the following conditions: Hypermobile EDS (hEDS).
What interventions are being tested in trial NCT06548594?
The interventions under investigation include: Transcutaneous Auricular Neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT06548594?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06548594 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.